Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer

Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer

Uterine cancer is the most prevalent gynecologic malignancy in women worldwide. Endometrial cancer (EC) has an 81% five-year survival rate, depending on disease stage and time of diagnosis. While endometrial cancer is largely treatable when detected early, no established screening techniques are ava...

Full description

Bibliographic Details
Main Authors: Hicham Benabdelkamel, Malak A. Jaber, Khalid Akkour, Reem H. AlMalki, Assim A. Alfadda, Afshan Masood, Salini Scaria Joy, Hani Alhalal, Moudi A. Alwehaibi, Maria Arafah, Eman Alshehri, Anas M. Abdel Rahman
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Metabolites
Subjects:
endometrial cancer
hyperplasia (HP)
metabolomics
LC-HRMS
energy metabolism
Online Access:https://www.mdpi.com/2218-1989/14/2/109

Internet

https://www.mdpi.com/2218-1989/14/2/109

Similar Items